ISBN: First Author / Trial name Meds optimisatio n Deliver DMPa Deterioration management Other Intensity (ave no. patient-professional encounters) Usual care High Risk - Mid-length interventions PREFER trial IV and SC medication, plus some investigations, could be done at home regular multi- disciplinary meetings, "person-centred care at home" model min. 1 face-to-face, actual mean 20 Primary care +/- additional measures as usual Y specifically titration of beta-blocker min. 3 face-to-face Primary care +/- other services as usual Y Given telephone number to contact during business hours. Could receive assessment and IV diuretics if needed at the clinic Actual ave 6 face-to-face Follow-up according to decision of treating cardiologist (not MDT) Y Y Contact number given, could be reviewed and admitted directly from clinic min. 3 face-to-face, actual median 6 contacts Primary care Gonzalez-Guerrero Y Y Could contact geriatrician every morning Global therapeutic regimen evaluated according to the capacities of the patient telephone Primary care, with referral to geriatrics at discretion J-HOMECARE trial Tsuchihashi-makaya Both intervention and control groups given emergency contact methods fixed 4 face-to-face (first (next 4 months) MDT discharge education (as per intervention). Routine management by cardiologist Y Contact number to leave message Fixed 4 face-to-face, plus telephone Routine discharge information. Primary care High Risk - Long interventions Auckland-HF Doughty x Y Could contact GP or clinic, recommend GP assessment in first instance min. 7 face-to-face (including GP) Primary care with other measures as usual Referral and approach to care Chronic Heart Failure NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: First Author / Trial name Meds optimisatio n Deliver DMPa Deterioration management Other Intensity (ave no. patient-professional encounters) Usual care Y Unclear Min. 